GlassScriptPhysician profile
Johnny C Yap
NPI 1790766269
$327.31
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $42.68 · 2022: $28.90 · 2023: $20.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $106.78 | 2019 | |
| Novocure INC. | $54.45 | 2019-2022 | |
| Tersera Therapeutics LLC | $44.14 | 2019 | |
| Siemens Medical Solutions USA, INC. | $42.68 | 2020 | |
| Palette Life Sciences, INC. | $20.08 | 2023 | |
| Amgen INC. | $18.68 | 2019 | |
| Incyte Corporation | $15.80 | 2019 | |
| Abbvie INC. | $12.67 | 2019 | |
| Celgene Corporation | $12.03 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Yap listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.